9,070€
0,83%
Echtzeit-Aktienkurs Clinuvel Pharmaceuticals Ltd.
Bid:
Ask:
Echtzeit-Chart der Clinuvel Pharmaceuticals Ltd. Aktie
Börsenkurse Clinuvel Pharmaceuticals Ltd.
| Börse Stuttgart | - | - | - | - | 9,070€ | 0,83% |
| Echtzeit Euro | - | - | - | - | 9,203€ | 1,24% |
| gettex | - | - | - | - | 9,188€ | 1,04% |
| Lang & Schwarz | - | - | - | - | 9,183€ | 0,99% |
| Tradegate | - | - | - | - | 9,205€ | 1,35% |
| Börse Frankfurt | - | - | - | - | 9,163€ | 0,47% |
Profil der Clinuvel Pharmaceuticals Ltd. Aktie
Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The firm engages in the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia.